Han Gao Selected Research

Han Gao Research Topics

Disease

22	Neoplasms (Cancer) 05/2022 - 01/2014
12	Inflammation (Inflammations) 01/2022 - 08/2011
10	Infections 01/2022 - 05/2014
6	Malaria 07/2021 - 12/2017
5	Hypoxia (Hypoxemia) 03/2022 - 01/2014
4	Neoplasm Metastasis (Metastasis) 01/2022 - 11/2017
4	Colitis 01/2022 - 01/2021
4	Lung Neoplasms (Lung Cancer) 01/2022 - 01/2021
4	Carcinogenesis 12/2021 - 01/2018
4	Carcinoma (Carcinomatosis) 06/2021 - 05/2010
3	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 08/2022 - 01/2021
3	Cardiovascular Diseases (Cardiovascular Disease) 07/2022 - 01/2014
3	Colorectal Neoplasms (Colorectal Cancer) 04/2022 - 01/2022
3	Keratitis 01/2022 - 01/2020
3	Body Weight (Weight, Body) 01/2022 - 01/2021
3	Fatigue 01/2022 - 02/2018
3	Ulcerative Colitis 01/2022 - 01/2020
3	Metabolic Diseases (Metabolic Disease) 11/2021 - 01/2019
3	Demyelinating Diseases (Demyelinating Disease) 01/2021 - 01/2017
3	Spinal Cord Injuries (Spinal Cord Injury) 10/2020 - 01/2013
3	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 01/2009
3	Hypertrophy 01/2018 - 06/2012
2	Crohn Disease (Crohn's Disease) 08/2022 - 01/2022
2	Esophageal Squamous Cell Carcinoma 11/2021 - 01/2020
2	Rectal Neoplasms (Rectal Cancer) 03/2021 - 07/2020
2	Cataract (Cataracts) 01/2021 - 01/2021
2	Obesity 01/2021 - 01/2019
2	Parkinson Disease (Parkinson's Disease) 06/2020 - 01/2018
2	Mitochondrial Diseases (Mitochondrial Disease) 11/2019 - 10/2017
2	Atherosclerosis 01/2019 - 01/2019
2	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 10/2017 - 01/2017
1	Paratuberculosis (Johne's Disease) 08/2022
1	Gliosis 06/2022
1	Constipation 05/2022
1	Pancreatic Neoplasms (Pancreatic Cancer) 05/2022
1	Meningioma (Meningiomas) 04/2022
1	Cerebral Infarction 03/2022
1	Thyroid Neoplasms (Thyroid Cancer) 01/2022
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2022

Drug/Important Bio-Agent (IBA)

14	Proteins (Proteins, Gene)FDA Link 03/2022 - 01/2014
7	CytokinesIBA 01/2022 - 01/2016
5	Messenger RNA (mRNA)IBA 03/2022 - 07/2013
5	Pharmaceutical PreparationsIBA 01/2022 - 04/2016
5	EnzymesIBA 02/2019 - 01/2009
4	Biomarkers (Surrogate Marker)IBA 08/2022 - 01/2020
4	RNA (Ribonucleic Acid)IBA 05/2022 - 01/2018
3	LipidsIBA 07/2022 - 01/2019
3	Biological ProductsIBA 05/2022 - 11/2017
3	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2022 - 01/2019
3	VaccinesIBA 01/2019 - 06/2013
3	AntibodiesIBA 01/2019 - 01/2009
2	Peptides (Polypeptides)IBA 08/2022 - 01/2009
2	Polycyclic Aromatic Hydrocarbons (Polynuclear Aromatic Hydrocarbons)IBA 07/2022 - 02/2021
2	Fatty Acids (Saturated Fatty Acids)IBA 05/2022 - 11/2021
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 04/2022 - 01/2018
2	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 01/2022 - 03/2021
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 01/2014
2	ErbB Receptors (EGF Receptor)IBA 01/2022 - 01/2021
2	CateninsIBA 01/2022 - 01/2021
2	Phosphotransferases (Kinase)IBA 01/2022 - 01/2021
2	Biocompatible Materials (Biomaterials)IBA 01/2022 - 12/2018
2	osimertinibIBA 01/2022 - 01/2021
2	DNA (Deoxyribonucleic Acid)IBA 12/2021 - 12/2019
2	Phospholipids (Phosphatides)FDA LinkGeneric 11/2021 - 07/2021
2	Long Noncoding RNAIBA 06/2021 - 01/2019
2	LigandsIBA 03/2021 - 01/2021
2	Type II Tumor Necrosis Factor ReceptorsIBA 01/2021 - 01/2017
2	artemisinin (artemisinine)IBA 01/2021 - 01/2020
2	Nitrous Oxide (Laughing Gas)IBA 01/2021 - 01/2020
2	Cytokine Receptors (Cytokine Receptor)IBA 01/2021 - 01/2018
2	PlatinumIBA 07/2020 - 01/2020
2	Glutamic Acid (Glutamate)FDA Link 06/2020 - 02/2019
2	SurvivinIBA 01/2020 - 01/2019
2	MicroRNAs (MicroRNA)IBA 01/2018 - 07/2013
2	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 01/2016
2	FlavonoidsIBA 04/2017 - 07/2016
2	icariinIBA 04/2017 - 07/2016
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2017 - 01/2016
2	Broadly Neutralizing AntibodiesIBA 05/2014 - 06/2013
2	AntigensIBA 06/2012 - 08/2011
1	Anti-Idiotypic AntibodiesIBA 08/2022
1	Galectin 3 (LGALS3)IBA 06/2022
1	B7 AntigensIBA 05/2022
1	flavoneIBA 03/2022
1	AlkaloidsIBA 01/2022
1	IronIBA 01/2022
1	HomocysteineIBA 01/2022
1	glabridinIBA 01/2022
1	MatrinesIBA 01/2022
1	Tyrosine Kinase InhibitorsIBA 01/2022
1	wumeiIBA 01/2022
1	Fibrinogen (Factor I)FDA Link 01/2022
1	ADP-ribosylation factor related proteinsIBA 01/2022

Therapy/Procedure

12	Therapeutics 03/2022 - 07/2013
2	Neoadjuvant Therapy 03/2021 - 07/2020
2	Intraocular Lenses (Intraocular Lens) 01/2021 - 01/2021
2	Transplantation 10/2020 - 01/2018
2	Drug Therapy (Chemotherapy) 07/2020 - 01/2020
1	Operative Surgical Procedures 04/2022
1	Treatment Delay 01/2022